Cargando…

Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Lin, Ming-Tzer, Kuo, Ping-Hung
Formato:	Texto
Lenguaje:	English
Publicado:	Royal Society of Medicine Press 2010
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984328/ https://www.ncbi.nlm.nih.gov/pubmed/21103098 http://dx.doi.org/10.1258/shorts.2009.090352

Ejemplares similares

Pulmonary lipiodol embolism following transcatheter arterial chemoembolization
por: Moriya, Tomohiro, et al.
Publicado: (2020)

Lipiodol Pneumonitis Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
por: Kim, Sungkeun, et al.
Publicado: (2020)

Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization
por: Kobayashi, Saito, et al.
Publicado: (2020)

Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular Carcinoma
por: Liu, Kai-Cai, et al.
Publicado: (2021)

Cerebral Lipiodol Embolism in Hepatocellular Carcinoma Patients Treated with Transarterial Embolization/Chemoembolization
por: Chu, Hai-Jui, et al.
Publicado: (2015)

Pancreas lipiodol embolism induced acute necrotizing pancreatitis following transcatheter arterial chemoembolization for hepatocellular carcinoma: A case report and literature review
por: Tan, Youwen, et al.
Publicado: (2019)

Efficacy and Safety of the Arsenic Trioxide/Lipiodol Emulsion in the Transcatheter Arterial Chemoembolization Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma
por: Li, Zhaonan, et al.
Publicado: (2021)

Pulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Nhu, Quan M, et al.
Publicado: (2016)

Comparison of the Efficacy of Two Microsphere Embolic Agents for Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients
por: Lee, Shao-Hua, et al.
Publicado: (2020)

Association of hepatic vein Lipiodol tram-track sign during transcatheter arterial chemoembolization with perioperative death
por: Zhao, Hongwei, et al.
Publicado: (2017)

The Degree of Lipiodol Accumulation Can Be an Indicator of Successful Treatment for Unresectable Hepatocellular Carcinoma (HCC) Patients - in the Case of Transcatheter Arterial Chemoembolization (TACE) and External Beam Radiotherapy (EBRT)
por: Yang, Ping, et al.
Publicado: (2016)

Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review
por: Shao, Zhiying, et al.
Publicado: (2021)

Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Hatanaka, Takeshi, et al.
Publicado: (2018)

Cerebral lipiodol embolism related to a vascular lake during chemoembolization in hepatocellular carcinoma: A case report and review of the literature
por: Ishimaru, Hideki, et al.
Publicado: (2018)

Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma
por: Yang, De-jun, et al.
Publicado: (2016)

Simultaneous transcatheter arterial chemoembolization and portal vein embolization for patients with large hepatocellular carcinoma before major hepatectomy
por: Zhang, Cheng-Wu, et al.
Publicado: (2020)

Transarterial Chemoembolization Using Gelatin Sponges or Microspheres Plus Lipiodol-Doxorubicin versus Doxorubicin-Loaded Beads for the Treatment of Hepatocellular Carcinoma
por: Liu, Yi-Sheng, et al.
Publicado: (2015)

Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
por: Liu, Yi-Sheng, et al.
Publicado: (2018)

Quality of Life after Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Compared with Transcatheter Arterial Chemoembolization alone
por: Hassanin, Taha M, et al.
Publicado: (2021)

A case of pulmonary foreign body granuloma formation after transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Murata, Saori, et al.
Publicado: (2021)

Transcatheter Arterial Chemoembolization Based on Hepatic Hemodynamics for Hepatocellular Carcinoma
por: Murata, Satoru, et al.
Publicado: (2013)

Transcatheter Arterial Chemoembolization Therapy for Patients With Unresectable Hepatocellular Carcinoma
por: Firouznia, Kavous, et al.
Publicado: (2014)

Hepatogastric Fistula following Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma
por: Grover, Inderpreet, et al.
Publicado: (2014)

The radiological prognostic factors of transcatheter arterial chemoembolization to hepatocellular carcinoma
por: Lee, Shou-Wu, et al.
Publicado: (2022)

Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization: Difficulties on Imaging Follow-up
por: Yu, Jeong-Sik
Publicado: (2005)

Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma
por: Huang, Yao-Kuang, et al.
Publicado: (2017)

Therapy-related myeloid neoplasms after transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Yi, Jun Ho, et al.
Publicado: (2021)

Efficacy of Stereotactic Body Radiotherapy for Recurrent or Residual Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization
por: Yao, Erhua, et al.
Publicado: (2018)

Assessment of Lipiodol Deposition and Residual Cancer for Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization via Iodine-Based Material Decomposition Images with Spectral Computed Tomography Imaging: A Preliminary Study
por: Xu, Yanhong, et al.
Publicado: (2015)

Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis
por: Cai, Rong, et al.
Publicado: (2017)

Chemolipiodolization with or without embolization in transcatheter arterial chemoembolization combined with radiofrequency ablation for hepatocellular carcinoma—propensity score matching analysis
por: Shi, Feng, et al.
Publicado: (2016)

Treatment strategy of adding transcatheter arterial chemoembolization to sorafenib for advanced stage hepatocellular carcinoma
por: Lee, Wei‐Chen, et al.
Publicado: (2020)

Cutaneous Metastasis of Hepatocellular Carcinoma Following Skin Injury after Transcatheter Arterial Chemoembolization
por: Cho, Eujin, et al.
Publicado: (2013)

Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma
por: Uchida‐Kobayashi, Sawako, et al.
Publicado: (2022)

Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma
por: NISHIKAWA, HIROKI, et al.
Publicado: (2012)

Spinal Cord Ischemia Secondary to Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
por: Bazine, Aziz, et al.
Publicado: (2014)

Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma
por: Liu, Chen, et al.
Publicado: (2016)

Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma
por: Takano, Michitoshi, et al.
Publicado: (2016)

The feasibility of transcatheter arterial chemoembolization following radiation therapy for hepatocellular carcinoma
por: Hamada, Mostafa, et al.
Publicado: (2021)

Ruptured Hepatic Carcinoma After Transcatheter Arterial Chemoembolization()
por: Jia, Zhongzhi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_83ltglbuvqh74tguirqpnvd5a4